Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

770

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

June 30, 2014

Conditions
Chronic Hepatitis C
Interventions
DRUG

Ypeginterferon alfa-2b

sc, qw, 24 weeks.

DRUG

Pegasys

sc, qw, 24 weeks.

DRUG

Ypeginterferon alfa-2b

sc, qw, 48 weeks.

DRUG

Pegasys

sc, qw, 48 weeks.

Trial Locations (42)

Unknown

302 Military Hospital, Beijing

Beijing Youan Hospital, Capital Medical University, Beijing

Beijing Youyi Hospital, capital Medical University, Beijing

Peking University First Hospital, Beijing

Peking University People's Hospital, Beijing

First Affiliated Hospital of Jilin University, Changchun

Xiangya Hospital, Central-south University, Changsha

Xiangya Second Hospital, Central-south University, Changsha

West China Hospital, Sichuan University, Chengdu

Second Affiliated Hospital Chongqing Medical University, Chongqing

Southwest Hospital, Chongqing

Fuzhou Infectious Disease Hospital, Fuzhou

Guangzhou Eighth People's Hospital, Guangzhou

Nanfang Hospital, Guangzhou

Third Affiliated Hospital of Sun Yat-sen University, Guangzhou

First Affiliated Hospital of Guangxi Medical University, Guilin

Affiliated Hospital of Guiyang Medical College, Guiyang

First Affiliated Hospital, Zhejiang University, Hangzhou

Second Affiliated Hospital of Harbin Medical University, Harbin

First Affiliated Hospital of Anhui Medical University, Hefei

Jinan Infectious Disease Hospital, Jinan

First Affiliated Hospital of Lanzhou University, Lanzhou

First Affiliated Hospital of Nanchang University, Nanchang

81 Military Hospital, Nanjing

Jiangsu Province Hospital, Nanjing

Second Hospital of Nanjing, Nanjing

85 Militay Hospital, Shanghai

Huashan Hospital, Shanghai

Renji Hospital, Shanghai

Ruijing Hospital, Shanghai

Shanghai Public Health Clinical Center, Shanghai

Third Affiliated Hospital, Hebei Medical University, Shijiazhuang

First Affiliated Hospital, Shanxi University, Taiyuan

Tianjin Third Central Hospital, Tianjin

First Affiliated Hospital of Xinjiang Medical University, Ürümqi

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Tangdu Hospital, Fourth Military Medical University, Xi'an

Xijing Hospital, Xi'an

The First Affiliated Hospital of Xiamen University, Xiamen

First Affiliated Hospital of Zhengzhou University, Zhengzhou

Hennan Provincial People's Hospital, Zhengzhou

All Listed Sponsors
lead

Xiamen Amoytop Biotech Co., Ltd.

INDUSTRY

NCT01581398 - Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C Patients | Biotech Hunter | Biotech Hunter